Cuprina Holdings (cayman) LTD F-1 registration statements

Cuprina Holdings (Cayman) Limited has filed an F-1 registration statement with the SEC to offer Class A Ordinary Shares, detailing its business in biomedical and biotechnology sectors, including chronic wound care and cosmeceuticals.

Cuprina Holdings (Cayman) Limited files Amendment No. 3 to its Form F-1 registration statement, primarily to include updated exhibits and related updates.

Cuprina Holdings, a Singapore-based biomedical firm, plans to raise capital through an initial public offering of Class A Ordinary Shares on the Nasdaq Capital Market.

Cuprina Holdings, a Singapore-based biomedical company, is planning an initial public offering of 3.75 million Class A Ordinary Shares on the Nasdaq Capital Market, aiming to raise capital for expansion and product development.

Cuprina Holdings, a Singapore-based biomedical company, has filed for an initial public offering on the Nasdaq Capital Market to fund the development and commercialization of its chronic wound care and cosmeceutical products.

Cuprina Holdings, a Singapore-based biomedical company, is seeking to raise capital through an initial public offering to expand its operations in chronic wound care and cosmeceuticals.

Cuprina Holdings, a Singapore-based biomedical firm, plans to raise capital through an initial public offering of 3.75 million Class A Ordinary Shares on the Nasdaq Capital Market.

Cuprina Holdings, a Singapore-based biomedical firm, is set to launch its initial public offering on the Nasdaq, aiming to raise $15.9 million while also facilitating a resale offering by existing shareholders.

Cuprina Holdings, a Singapore-based biomedical firm, is set to launch its initial public offering (IPO) aiming to raise $15.9 million while also facilitating a resale of shares by existing stakeholders.

Cuprina Holdings (Cayman) Limited is set to launch its initial public offering of 3,750,000 Class A Ordinary Shares, aiming for a Nasdaq listing under the ticker CUPR.

Cuprina Holdings (Cayman) Limited files an amendment to its Form F-1 registration statement for its initial public offering of Class A Ordinary Shares, with a resale prospectus included.

Cuprina Holdings (Cayman) Limited files an amendment to its Form F-1 registration statement for a proposed initial public offering of 2,500,000 Class A Ordinary Shares, along with a resale prospectus for 1,500,000 Class A Ordinary Shares.

Cuprina Holdings (Cayman) Limited files for an initial public offering of 2,500,000 Class A Ordinary Shares, alongside a resale offering of 1,500,000 Class A Ordinary Shares by existing shareholders, seeking to list on the Nasdaq Capital Market under the ticker CUPR.

Cuprina Holdings (Cayman) Limited files for an initial public offering of 2,500,000 Class A Ordinary Shares, alongside a resale offering of 1,500,000 Class A Ordinary Shares by existing shareholders, seeking a Nasdaq listing under the symbol CUPR.

Cuprina Holdings, a Singapore-based biomedical company, has filed for an initial public offering to list its Class A Ordinary Shares on the Nasdaq Capital Market.